New rules could hurt drug takeback programs

The U.S. Drug Enforcement Agency has proposed rule changes for drug takeback programs that forbid authorities from gathering data on what drugs are being returned and in what quantities. Such data has been used to reduce the cost of MaineCare -- the state's Medicaid program -- by imposing 15-day limits on the initial prescriptions of often-wasted drugs, many of which are opiates.
CLICK TO VIEW THE SOURCE MATERIAL